In March 2025, the company declared new ideas for any immediate-to-consumer offering of its Wegovy weight loss drug. The company set up a whole new pharmacy, identified as NovoCare, which would charge prospects $499 a month for access to the drug, fewer than 50 percent the expense of the drug by other pharmaceutical distribution networks.[fifty thr